AI-generated summary
The authors followed 75 patients with non-exudative central involution chorioretinal dystrophy who received low-intensity laser therapy at 890 nm, 644 nm or 500 nm. They report that visual acuity and retinal sensitivity improved most with 890 nm, less with 500 nm, and least with 640 nm, with results measured right after treatment and at 3 months.
- Participants
- 75
- Who or what was studied
- Patients with non-exudative central involution chorioretinal dystrophy at the progression stage (75 eyes)
- Wavelengths
- 890, 644, 500 nm
- Limits stated in the abstract
- The abstract does not describe a control group, randomization, or statistical testing, and it reports 640 nm while the methods state 644 nm.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on pubmed.ncbi.nlm.nih.gov.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 890 nm, 644 nm, 500 nm, 640 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.